Related Experiment Videos
Multiple endocrine neoplasia type 2b with a good prognosis
Archives of Internal Medicine
|June 1, 1987
Summary
Multiple Endocrine Neoplasia syndrome type 2b (MEN 2b) can have an indolent course, even with metastases. Patient outcomes suggest factors beyond inheritance influence disease progression.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Multiple Endocrine Neoplasia syndrome type 2b (MEN 2b) is a rare genetic disorder.
- It is characterized by medullary thyroid carcinoma, pheochromocytomas, and other tumors.
- MEN 2b typically has a more aggressive clinical course compared to MEN 2a.
Observation:
- This study describes three MEN 2b patients with a favorable prognosis.
- Minimal progression of medullary thyroid carcinoma metastases was observed over 41-84 months.
- One patient had liver metastases present for over 22 years with little change.
Findings:
- The clinical course of MEN 2b can be indolent, similar to MEN 2a or sporadic tumors.
- Disease progression in MEN 2b may be less aggressive than previously assumed, even with metastases.
- Bilateral pheochromocytomas were successfully removed in two patients.
Implications:
- These findings challenge the general view of MEN 2b as uniformly aggressive.
- Factors other than genetic inheritance likely play a significant role in MEN 2b patient outcomes.
- Further research into these contributing factors could lead to improved management strategies for MEN 2b.